These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8680115)

  • 1. The effects of thromboxane A2 synthetase inhibitor (OKY-046) on complete hepatic ischemia in rats with obstructive jaundice.
    Takahashi T
    Surg Today; 1996; 26(1):15-20. PubMed ID: 8680115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of thromboxane A2 synthesis inhibitor (OKY-046) on total liver ischemia in rats.
    Kobayashi T; Esato K; Morita N; Noshima NS
    Int Surg; 1996; 81(2):115-8. PubMed ID: 8912073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The protective effect of thromboxane A2 synthetase inhibitor against ischemic liver injury.
    Isozaki H; Okajima K; Hara H; Kobayashi M
    Surg Today; 1994; 24(5):435-40. PubMed ID: 8054815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of thromboxane A2 activity during warm ischemia of the liver.
    Shirabe K; Kin S; Shinagawa Y; Chen S; Payne WD; Sugimachi K
    J Surg Res; 1996 Feb; 61(1):103-7. PubMed ID: 8769950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of thromboxane synthetase inhibitor on non-heart-beating donors in rat orthotopic liver transplantation.
    Soejima Y; Yanaga K; Nisizaki T; Yoshizumi T; Uchiyama H; Sugimachi K
    Surgery; 1998 Jan; 123(1):67-72. PubMed ID: 9457225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combined use of prostaglandin I2 analogue (OP-2507) and thromboxane A2 synthetase inhibitor (OKY-046) strongly inhibits atherosclerosis of aortic allografts in rats.
    Hirano T; Nakafusa Y; Kawano R; Motoyama K; Arima T; Sugitani A; Tanaka M
    Surgery; 2001 May; 129(5):595-605. PubMed ID: 11331452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the thromboxane A2 synthetase inhibitor OKY-046 in a warm ischemia-reperfusion rat model.
    Garvin PJ; Niehoff ML; Robinson SM; Heisler T; Salinas-Madrigal L; Contis J; Solomon H
    Transplantation; 1996 May; 61(10):1429-34. PubMed ID: 8633364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a thromboxane synthetase inhibitor (OKY-046) in an ischemia-reperfusion model of intrauterine growth retardation in Sprague-Dawley rats.
    Tanaka M; Natori M; Ishimoto H; Miyakoshi K; Miyazaki T; Kobayashi T; Yoshimura Y
    Biol Neonate; 1997; 72(3):181-6. PubMed ID: 9303217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of a thromboxane synthetase inhibitor, OKY-046, on urinary excretion of immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in patients with ischemic cerebrovascular disease.
    Uyama O; Nagatsuka K; Nakabayashi S; Isaka Y; Yoneda S; Kimura K; Abe H
    Stroke; 1985; 16(2):241-4. PubMed ID: 3883580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the infusion of OKY-046, a thromboxane A2 synthase inhibitor, on urinary metabolites of prostacyclin and thromboxane A2 in healthy human subjects.
    Morio H; Hirai A; Terano T; Tamura Y; Yoshida S
    Thromb Haemost; 1993 Mar; 69(3):276-81. PubMed ID: 8470052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of thromboxane A2 synthesis by OKY-046 attenuates ischemia and reperfusion injury of the liver.
    Iida J; Shimamura T; Suzuki T; Jin MB; Taniguchi M; Fukai M; Yokota R; Horiuchi H; Magata S; Kishida A; Furukawa H; Todo S
    Transplant Proc; 1999; 31(1-2):1061-2. PubMed ID: 10083474
    [No Abstract]   [Full Text] [Related]  

  • 12. [Beneficial effect of a selective TXA2 synthetase inhibitor, OKY-046, both on thromboxane B2 production and vascular damage after spinal cord injury in rat spinal cord].
    Morimoto K; Ikata T; Tounai T
    Nihon Seikeigeka Gakkai Zasshi; 1990 Jan; 64(1):82-8. PubMed ID: 2319197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of thromboxane synthetase inhibitor on cerebral circulation and metabolism during experimental cerebral ischemia in spontaneously hypertensive rats.
    Sadoshima S; Ooboshi H; Okada Y; Yao H; Ishitsuka T; Fujishima M
    Eur J Pharmacol; 1989 Oct; 169(1):75-83. PubMed ID: 2513212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of a thromboxane A2 synthesis inhibitor and a prostaglandin I2 analogue on experimental acute necrotizing pancreatitis in rats.
    Iida T; Yokoi H; Kawarada Y
    Pancreas; 1998 Aug; 17(2):140-7. PubMed ID: 9700944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of TXA synthesis with OKY-046 improves liver preservation by prolonged hypothermic machine perfusion in rats.
    Xu H; Lee CY; Clemens MG; Zhang JX
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e212-20. PubMed ID: 17645480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of thromboxane synthetase inhibitors (OKY-046, OKY-1580) on experimentally induced air embolism in anesthetized dogs.
    Ishihara Y; Uchida Y; Kitamura S
    Prostaglandins Leukot Med; 1986 Feb; 21(2):197-206. PubMed ID: 3457388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of thromboxane A2-thromboxane A2 receptor system of the hepatic sinusoid in pathogenesis of cold preservation/reperfusion injury in the rat liver graft.
    Ishiguro S; Arii S; Monden K; Fujita S; Nakamura T; Niwano M; Harada T; Ushikubi F; Narumiya S; Imamura M
    Transplantation; 1995 Apr; 59(7):957-61. PubMed ID: 7709455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo enhancement of platelet activating factor-induced prostacyclin production by OKY-046, a selective inhibitor of thromboxane A2 synthase.
    Davenport NJ; Goldstein RE; Feuerstein GZ
    J Cardiovasc Pharmacol; 1991 Apr; 17(4):641-6. PubMed ID: 1711633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of prostanoid in hepatic damage during hepatectomy.
    Shirabe K; Takenaka K; Yamamoto K; Kitamura M; Itasaka H; Matsumata T; Shimada M; Sugimachi K
    Hepatogastroenterology; 1996; 43(9):596-601. PubMed ID: 8799402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a selective thromboxane synthetase inhibitor OKY-046 on experimental diabetic nephropathy.
    Hora K; Oguchi H; Furukawa T; Hora K; Tokunaga S
    Nephron; 1990; 56(3):297-305. PubMed ID: 2077412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.